Infective endocarditis in maintenance hemodialysis patients: Fifteen years' experience in one medical center

Journal of Nephrology

Volumn 17, Issue 2, 2004, Pages 228-235

  Chang, Chao Fu ^a   Kuo, Benjamin Ing Tiau ^b   Chen, Te Li ^b   Yang, Wu Chang ^a   Lee, Shou Dong ^a   Lin, Chih Ching ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Echocardiogram; Hemodialysis; Infective endocarditis; Methicillin resistant S. aureus

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CALCIUM; GLUCOSE; METICILLIN; PHOSPHATE;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ANAMNESIS; ANTIBIOTIC THERAPY; ARTERIOVENOUS FISTULA; ARTICLE; ARTIFICIAL HEART PACEMAKER; BACTERIAL ENDOCARDITIS; CATHETER; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; EXPERIENCE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE FACILITY; HEART SURGERY; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; MAINTENANCE THERAPY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL PARAMETERS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; PATHOGENESIS; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL;

AGED; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 2942654753     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Avram MM. Survival in uremia due to systemic diseases. Kidney Int 1978; 8 (suppl): S50-60.
2. Lazarus JM, Lowrie EG, Hampers CL, Merrill JP. Cardiovascular disease in uremic patients on hemodialysis. Kidney Int 1975; 2 (suppl): S167-75.
3. Hanslik T, Flahault A, Vaillant JN, Boulard JC, Moulonguet-Doleris L, Prinseau J, Baglin A. High risk of severe endocarditis in patients on chronic dialysis. Nephrol Dial Transplant 1997; 12: 1301-2.
4. Robinson DL, Fowler VG, Sexton DJ, Corey RG, Conlon PJ. Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis 1997; 30: 521-4.
5. Leonard A, Raij L, Shapiro FL. Bacterial endocarditis in regularly dialyzed patients. Kidney Int 1973; 4: 407-22.
6. Dobkin JF, Miller MH, Steigbigel NH. Septicemia in patients on chronic hemodialysis. Ann Intern Med 1978; 88: 28-33.
7. Stratton J, Macdonald A, Farrington K. Successful treatment of MRSA endocarditis in a haemodialysis patient. Nephrol Dial Transplant 2000; 15: 1719-20.
8. Egoh Y, Ogura K, Anbe J, Nakajima H, Ohkoshi T, Akasaka T. A case report of active infectious endocarditis caused by MRSA with chronic renal failure. Kyobu Geka 1996; 49: 677-9.
9. Quarles LD, Rutsky EA, Rostand SG. Staphylococcus aureus bacteremia in patients on chronic hemodialysis. Am J Kidney Dis 1985; 6: 412-9.
10. Maher ER, Young G, Smyth-Walsh B, Pugh S, Curtis JR. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 1987; 2: 875-7.
11. Durack DT, Lukes AS, Bright DY, New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96: 200-9.
12. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001; 345: 1318-30.
13. Maraj S, Jacobs LE, Kung SC, Raja R, Krishnasamy P, Maraj R, Braitman LE, Kotler MN. Epidemiology and outcome of infective endocarditis in hemodialysis patients. Am J Med Sci 2002; 324: 254-60.
14. Karchmer AW. Infective endocarditis. In Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, Eds. Harrison's principles of internal medicine. New York: McGraw-Hill, 2001; 809-16.
15. Haag-Weber M, Horl WH. Uremia and infection: mechanisms of impaired cellular host defense. Nephron 1993; 63: 125-31.
16. Moukarbel GV, Tabbarah ZA, Khoury MY. Successful treatment of pacemaker related endocarditis with acute embolic stroke without device removal. J Interv Card Electrophysiol 2003; 9: 39-42.
17. Mokaddem A, Bachraoui K, Sdiri W, Kachboura S, Boujnah MR. Pacemaker infections. Tunis Med 2002; 80: 509-14.
18. Rallidis LS, Komninos KA, Papasteriadis EG. Pacemaker-related endocarditis: the value of transoesophageal echocardiography in diagnosis and treatment. Acta Cardiol 2003; 58: 31-4.
19. Erdinler I, Okmen E, Zor U, Zor A, Oguz E, Ketenci B, Akyol A, Aytekin S, Ulufer T. Pacemaker related endocarditis: analysis of seven cases. Jpn Heart J 2002; 43: 475-85.
20. Banos R, Gomez J, Sanchez B, de la Morena G, Simarro E, Garcia del Real F. Pacemaker led endocarditis: analysis of 11 cases. Enferm Infecc Microbiol Clin 2000; 18: 267-70.
21. Doulton T, Sabharwal N, Cairns HS, Schelenz S, Eykyn S, O'Donnell P, Chambers J, Austen C, Goldsmith DJ. Infective endocarditis in dialysis patients: new challenges and old. Kidney Int 2003; 64: 720-7.
22. McCarthy JT, Steckelberg JM. Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc 2000; 75: 1008-14.
23. Takahashi C, Warrak EA, Ruzany F. Infectious endocarditis in patients on periodic hemodialysis. Rev Assoc Med Bras 1991; 37: 119-26.
24. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999; 34: 1114-24.
25. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997; 127: 275-80.
26. Little MA, O'Riordan A, Lucey B, Farrell M, Lee M, Conlon PJ, Walshe JJ. A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters. Nephrol Dial Transplant 2001; 16: 2194-200.
27. Watanakunakorn C, Baird IM. Staphylococcus aureus bacteremia and endocarditis associated with a removable infected intravenous device. Am J Med 1977; 63: 253-6.
28. Fernandez-Cean J, Alvarez A, Burguez S, Baldovinos G, Larre-Borges P, Cha M. Infective endocarditis in chronic haemodialysis: two treatment strategies. Nephrol Dial Transplant 2002; 17: 2226-30.
29. Follin SL, Mueller BA, Scott MK, Carfagna MA, Kraus MA. Falsely elevated serum vancomycin concentrations in hemodialysis patients. Am J Kidney Dis 1996; 27: 67-74.
30. Marr KA, Kong L, Fowler VG, Gopal A, Sexton DJ, Conlon PJ, Corey GR. Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int 1998; 54: 1684-9.
31. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HIPAC). Infect Control Hosp Epidemiol 1995; 16: 105-13.
32. Marciante KD, Veenstra DL, Lipsky BA, Saint S. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use. Am J Infect Control 2003; 31: 1-8.
33. Walder B, Pittet D, Tramer MR. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect Control Hosp Epidemiol 2002; 23: 748-56.
34. Pai MP, Pendland SL, Danziger LH. Antimicrobial-coated/bonded and -impregnated intravascular catheters. Ann Pharmacother 2001; 35: 1255-63.
35. Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, Yeoh H, Law D, Robbins JB, Schneerson R, Muenz L, Fuller S, Johnson J, Fireman B, Alcorn H, Naso R. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002; 346: 491-6.
36. Sesso R, Barbosa D, Leme IL, Sader H, Canziani ME, Manfredi S, Draibe S, Pignatari AC. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol 1998; 9: 1085-92.
37. Ladavac R, Vranic-Ladavac M, Jerin L. Local application of mupirocin ointment in the eradication of Staphylococcus aureus from nasal mucosa in patients on chronic hemodialysis. Acta Med Croatica 1997; 51: 211-3.